Treatment modalities include liver transplantation for transthyretin-related (ATTR) amyloidosis, elimination of inflammation in amyloid A (AA) amyloidosis and intensive chemotherapy in ...

Treatment type may impact life expectancy. Liver transplantation: Until the recent approval of drug therapies for hATTR amyloidosis, liver transplantation was the only available treatment.

which constitutes 50% of the deaths in patients with primary amyloidosis. This includes assessing shortness of breath (even with the slightest exertion), peripheral edema, enlarged liver ...

Early clinical diagnosis of an under-recognized form of amyloidosis that causes rapidly progressing polyneuropathy is crucial to improving patient outcomes. Worldwide, the most common mutation ...

Amvuttra operates via RNA interference (RNAi), a groundbreaking technology that inhibits the production of the TTR protein in ...

Transthyretin Amyloidosis Treatment Market explores key drug advances, regulatory developments, and growth trends through 2035 ...

"Eplontersen has the potential to halt the progression of TTR-mediated amyloidosis ... "Thanks to its precise liver-targeting properties, it also has the potential to be a best-in-class treatment ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...